Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Hidradenitis suppurativa is a chronic skin condition causing painful lumps and scarring, often triggered by smoking and obesity, and requires varying treatments based on severity.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Standardized forms and digital tools can improve alopecia biopsy diagnosis.

CCCA mainly affects Black women and is linked to high-tension hairstyles, heating tools, chemical relaxants, and genetics.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Phenoxyethanol in hair growth products may be linked to frontal fibrosing alopecia.

A boy with Pachyonychia congenita has a confirmed gene mutation, highlighting the need for a local genetic database in India.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

Gefitinib can cause scalp skin issues and permanent hair loss.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Dermaroller is effective and safe for improving skin conditions like acne scars and alopecia with minimal side effects.

PRP works well with other treatments for better skin, hair, and scar results.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

A scarring hair loss condition mainly affects middle-aged women of African descent, impacting their quality of life, with treatments more effective when started early.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

Early diagnosis and treatment of hair loss in children are crucial to prevent permanent damage.

A new method improves alopecia diagnosis using non-invasive steps.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Tissue engineering in cosmetics offers safer, more effective products and ethical alternatives to animal testing.